MWA
ENZ

Medallion Wealth Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

Medallion Wealth Advisors’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,800
Closed -$1.04K – 1134
2025
Q1 		$1.04K Hold
2,800
– – ﹤0.01% 983
2024
Q4 		$1.04K Buy
+2,800
New +$2.9K ﹤0.01% 922

Other funds holding ENZ

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

Medallion Wealth Advisors's ENZ Position: Q2 2025 in Review

Medallion Wealth Advisors sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 2,800 shares — an estimated $1.04K sold.

Medallion Wealth Advisors first reported a position in ENZ in Q4 2024 and held it in 2 quarters. The position peaked at $1.04K in Q1 2025. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

  • Medallion Wealth Advisors reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
  • Medallion Wealth Advisors sold 2,800 Enzo Biochem, Inc. shares in Q2 2025, an estimated $1.04K.
  • Medallion Wealth Advisors first reported a position in Enzo Biochem, Inc. in Q4 2024 and held it in 2 quarters.
  • Medallion Wealth Advisors's Enzo Biochem, Inc. position peaked at $1.04K in Q1 2025.
  • 6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on Medallion Wealth Advisors's 13F filing for Q2 2025, filed 24 Apr 2026.